Copyright
©The Author(s) 2021.
World J Gastrointest Oncol. Dec 15, 2021; 13(12): 2203-2215
Published online Dec 15, 2021. doi: 10.4251/wjgo.v13.i12.2203
Published online Dec 15, 2021. doi: 10.4251/wjgo.v13.i12.2203
Figure 1 PRISMA flow-chart.
Figure reported the diagram of our systematic review of the literature, performed in 4 databases from Jan 1, 2009 up to Jan 1, 2021. Search terms included: "cholangiocarcinoma", "intrahepatic", "laparoscopic", "surgery", "minimally invasive", "robotic surgery" "biliary neoplasm", "liver resection" and "hepatectomy". Inclusion criteria are in the big circle-box. Major reasons for exclusion were the absence of patients treated both with laparoscopic and open approach (n = 114) and the inclusion of other tumor types besides intrahepatic cholangiocarcinoma (n = 36). Further reasons for exclusion were population treated with palliative intent or case series or absence of specific data on the post-operative outcomes. This led to the final selection of 9 studies which fulfilled the inclusion criteria. ICC: Intrahepatic cholangiocarcinoma.
- Citation: Patrone R, Izzo F, Palaia R, Granata V, Nasti G, Ottaiano A, Pasta G, Belli A. Minimally invasive surgical treatment of intrahepatic cholangiocarcinoma: A systematic review. World J Gastrointest Oncol 2021; 13(12): 2203-2215
- URL: https://www.wjgnet.com/1948-5204/full/v13/i12/2203.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v13.i12.2203